ASRS
RARE icon

Arizona State Retirement System’s Ultragenyx Pharmaceutical RARE Stock Holding History

Arizona State Retirement System’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$770K Sell
23,059
-791
-3% -$19.6K ﹤0.01% 1317
2026
Q1 		$500K Sell
23,850
-119
-0.5% -$2.68K ﹤0.01% 1458
2025
Q4 		$551K Sell
23,969
-1,207
-5% -$39.7K ﹤0.01% 1422
2025
Q3 		$757K Buy
25,176
+533
+2% +$16K ﹤0.01% 1286
2025
Q2 		$896K Buy
24,643
+814
+3% +$29.3K 0.01% 1145
2025
Q1 		$863K Sell
23,829
-209
-0.9% -$8.7K 0.01% 1138
2024
Q4 		$1.01M Buy
24,038
+568
+2% +$28.2K 0.01% 1094
2024
Q3 		$1.3M Buy
23,470
+2,726
+13% +$139K 0.01% 972
2024
Q2 		$853K Buy
20,744
+434
+2% +$18.5K 0.01% 1110
2024
Q1 		$948K Buy
20,310
+227
+1% +$10.7K 0.01% 1068
2023
Q4 		$960K Sell
20,083
-80
-0.4% -$3.1K 0.01% 1065
2023
Q3 		$719K Buy
20,163
+441
+2% +$17.5K 0.01% 1178
2023
Q2 		$910K Buy
19,722
+425
+2% +$19.7K 0.01% 1075
2023
Q1 		$774K Buy
19,297
+523
+3% +$22.4K 0.01% 1138
2022
Q4 		$870K Buy
18,774
+721
+4% +$28.4K 0.01% 1050
2022
Q3 		$748K Buy
18,053
+190
+1% +$9.76K 0.01% 1089
2022
Q2 		$1.07M Buy
17,863
+359
+2% +$22.1K 0.01% 930
2022
Q1 		$1.27M Buy
17,504
+159
+0.9% +$11.1K 0.01% 935
2021
Q4 		$1.46M Sell
17,345
-118
-0.7% -$9.6K 0.01% 885
2021
Q3 		$1.57M Buy
17,463
+174
+1% +$15.7K 0.01% 847
2021
Q2 		$1.65M Sell
17,289
-1,006
-5% -$105K 0.01% 829
2021
Q1 		$2.08M Buy
18,295
+1,602
+10% +$218K 0.02% 711
2020
Q4 		$2.31M Sell
16,693
-435
-3% -$51.6K 0.02% 628
2020
Q3 		$1.41M Buy
17,128
+4,715
+38% +$391K 0.01% 759
2020
Q2 		$971K Sell
12,413
-471
-4% -$31.2K 0.01% 773
2020
Q1 		$572K Buy
+12,884
New +$669K 0.01% 938

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Arizona State Retirement System's RARE Position: Q2 2026 in Review

Arizona State Retirement System reduced its Ultragenyx Pharmaceutical (RARE) stake by 3.3% in Q2 2026, selling an estimated $19.6K and leaving 23,059 shares worth $770K. The position accounts for ﹤0.01% of the portfolio, ranked #1317.

Arizona State Retirement System first reported a position in RARE in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.31M in Q4 2020. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Arizona State Retirement System held 23,059 shares of Ultragenyx Pharmaceutical worth $770K as of Q2 2026.
  • Arizona State Retirement System sold 791 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $19.6K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1317 holding.
  • Arizona State Retirement System first reported a position in Ultragenyx Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • Arizona State Retirement System's Ultragenyx Pharmaceutical position peaked at $2.31M in Q4 2020.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.